期刊文献+

T2和T3期膀胱癌术后放射治疗及膀胱内灌注化疗疗效分析 被引量:5

Postoperative radiotherapy combined with intravesical chemotherapy for T2/T3 bladder cancer
原文传递
导出
摘要 目的 分析T2、T3期膀胱移行细胞癌行部分膀胱切除术后放射治疗及膀胱内灌注治疗疗效。方法 回顾性分析本院 93例膀胱癌行部分膀胱切除术后放射 +化疗疗效 ,其中 5 8例接受放射治疗及灌注化疗 (放 +灌组 ) ,35例仅接受膀胱内灌注化疗 (灌注组 )。放射治疗采用 8或 18MVX射线 ,照射剂量为 5 0~ 6 0Gy。膀胱内灌注采用噻替哌或卡介苗 ,前者 5 0~ 6 0mg/次 ,2次 /周 ,共 6次 ;后者 0 .5mg/次 ,1次 /周 ,共 3次。结果 放 +灌组和灌注组 3年局部控制率分别为 6 8.6 %、48.2 %(χ2 =4.0 8,P =0 .0 44 ) ;1、3、5年生存率分别为 94.7%、70 .7%、49.5 %和 87.2 %、5 9.9%、35 .7% (χ2 =1.77,P =0 .184) ;放 +灌组生存 5年者有 78.6 %保存膀胱。放 +灌组放射反应大 ,但患者都能耐受。结论 T2、T3期膀胱移行细胞癌行部分膀胱切除术后放射治疗 +膀胱内灌注化疗可以降低局部复发。 Objective To compare the result of T2/T3 transitional cell carcinoma (TCC) of the urinary bladder after segmental cystectomy, treated by postoperative radiation plus intravesical chemotherapy and postoperative intravesical chemotherapy alone.Methods From 1985 to Dec.1995 patients with T2/T3 TCC bladder cancer who had been treated by segmental cystectomy were eligible for this retrospective analysis. Fifty-eight patients received postoperative radiotherapy plus intravesical chemotherapy (RT+IVC) and 35 patients were given postoperative intravesical chemotherapy (IVC) with thio-TEPA or calmette-Gue'rin bacilli (BCG). For radiation,8 or 18 ?MV X-ray was given with total dose of 50-60 ?Gy. Vesicoclysis was performed on 50-60 mg thio-TEPA twice per week and 0.5 mg BCG per week.Results The 3-year local control rates of RT+IVC and IVC groups were 68.6% and 48.2% showing a difference statistically significant (χ 2=4.08,P=0.044).The 3- and 5-year survival rates of RT+IVC and IVC groups were 70.7%,49.5% and 59.9%,35.7% ,showing no significant difference (χ 2=1.77,P=0.184). Among the 5 year survivors of the RT+IVC patients, 78.6% had their bladder preserved. Though untoward radiation reactions were severer, they were tolerated well.Conclusions Combined radiation therapy plus intravesical chemotherapy is indicated for T2/T3 bladder cancer after segmental cystectomy. Multimodality therapy is more favored to improve both the local control and the possibility of preserving the bladder.
出处 《中华放射肿瘤学杂志》 CSCD 北大核心 2002年第2期118-120,共3页 Chinese Journal of Radiation Oncology
关键词 膀胱癌 放射疗法 化学疗法 膀胱灌注 Bladder neoplasms/radiotherapy Bladder neoplasms/chemotherapy Bladder perfusion
  • 相关文献

参考文献2

共引文献1

同被引文献36

  • 1沈德炘,赵锡生,陈平康,金保庚,毛永杰,王震吾.膀胱癌术中放射治疗[J].中华泌尿外科杂志,1994,15(1):40-41. 被引量:3
  • 2李劲松,徐兴钊,丁吉元,曾林.膀胱移行细胞癌患者预后因素的多元分析[J].中华外科杂志,1995,33(6):353-354. 被引量:4
  • 3潘进勇,王晓雄.膀胱小细胞癌的研究进展[J].中华肿瘤防治杂志,2007,14(11):864-867. 被引量:7
  • 4张元芳 王忠.膀胱肿瘤[A].见:汤钊猷主编.现代肿瘤学:第2版[C].上海:上海医科大学出版社,2000.1182.
  • 5李长青.泌尿系统肿瘤[A].见:刘泰福主编.现代放射肿瘤学[C].上海:复旦大学出版社,2001.295-304.
  • 6Arias F, Dominguez MA, Martinez E, et al. Chemoradiotherapy for muscul invading bladder carcinoma. Fanal report of single institutional organ sparing program [J ]. Int J Radiat Oncol Biol Phys,2000,47(2):373.
  • 7Shipley WU, Zietman AL, Kaufman DS, et al. Invasive bladder cancer: treatment strategies using transurethral surgery, chemotherapy and radiation thrapy with selection for bladder conservation[J]. Int J Radiat Oncol Biol Phys, 1997,39(4) :937.
  • 8Kachnic LA, Kaufman DS, Heney NM, et al. Bladder preservation by combined therapy for invasive bladder cancer[J ]. J Clin Oncol, 1997,15(3) : 1022.
  • 9Arias F, Duena M, Martinez F, ct al. Padical chemoradiotherapy for elderly patients with bladder carcinoma invading muscle [J].Cancer, 1997, 80(1):115 - 120
  • 10Rodel C, Grabenbauer GG, Kuhn R, et al. Combined-modality treatment and selective organ preservation in invasive bladder cancer: Long-term results[J].J Clin Oncol, 2002, 20(4):3061-3071

引证文献5

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部